Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Skin Aging: later-stage trial registry

A small indexed set (10 trials) with no open enrollment listed right now.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · none currently recruiting · #1,724 of 28,707 conditions by registered trial count

Skin Aging: 10 US clinical trials tracked, none currently recruiting.

Skin Aging is the subject of 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Victoria Collotta, running 2 of these trials.

Enrollment posture brief

Registry condition skin-aging

OPEN 0 | RECR 0% | LATE 2 | EARLY 1 | RANK #1724 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%Skin Aging (this)0%
Open-enrollment share among volume-matched conditions near Skin Aging

Skin Aging has no open enrollment in this registry pull (10 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Skin Aging on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Skin Aging is recruiting below its size-band peers.

    0 of 10 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Skin Aging research.

    Victoria Collotta accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Most Skin Aging trials plan to enrol fewer than 100 people.

    Median target enrolment is 45 among the 10 trials that report a genuine target (sentinel values excluded). 8 of those (80%) plan for fewer than 100 participants.

  4. Skin Aging research is mostly interventional.

    10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31Phase 41

Indexed trials (enrollment closed)

10 total, page 1 of 1

ACTIVE NOT RECRUITING NA 40 participants

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

Victoria Collotta

NCT06804759

ACTIVE NOT RECRUITING NA 15 participants

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo

Victoria Collotta

NCT06804772

ACTIVE NOT RECRUITING Early Phase 1 12 participants

Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure

Johns Hopkins University

NCT03730649

COMPLETED Phase 3 247 participants

Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Revance Therapeutics

NCT01776606

COMPLETED NA 156 participants

Relationship of Skin Related SNP to Topical Skin Care Product

HelicalCodeMD

NCT03446079

COMPLETED NA 63 participants

Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women

Natals, Inc. dba Ritual

NCT06083402

COMPLETED NA 50 participants

Thermage CPT for Treatment of Facial and Neck Laxity

Valeant Pharmaceuticals

NCT01783496

COMPLETED Phase 4 45 participants

Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules

Advanced Dermatology

NCT02765763

COMPLETED NA 33 participants

Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health

Truology

NCT06853899

COMPLETED NA 18 participants

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging

Crown Laboratories

NCT05030051

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Skin Aging records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Investigational Facial Serum #3 Other
2 trials
Investigational Facial Serum #2 Other
2 trials
Investigational Facial Serum #1 Other
2 trials
Null Formula 24/7 Barrier Repair Cream Drug
1 trials
Null Formula 2-Minute Reveal Masque Drug
1 trials
8-in-1 BioSerum Drug
1 trials
24/7 Barrier Repair Cream Drug
1 trials
2-Minute Reveal Masque Drug
1 trials

US sites by state

Facility locations filed on Skin Aging trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
California 2 trials
Texas 1 trials
Nevada 1 trials
New Jersey 1 trials
Maryland 1 trials
Illinois 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Skin Aging page

10 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Skin Aging trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Victoria Collotta sponsors the most Skin Aging trials on record, review their full trial history before evaluating a specific study. See Victoria Collotta's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin Aging condition card totals 10 registered trials; most-linked intervention Investigational Facial Serum #3; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.